Skip to main content

Advertisement

Therapeutic considerations in the treatment of major psychiatric disorders

Article metrics

  • 924 Accesses

The pharmacological treatment of major psychiatric disorders is based on antipsychotic medication (for schizophrenia and manic episodes of mood disorders) and on antidepressants (for the depressive episodes of mood disorders). The main pharmacotherapeutic considerations concern efficacy, side-effects and tolerability. These issues are related to pharmacodynamic and pharmacokinetic characteristics of the various medications such as the affinity to various receptors, selectivity to those which are most relevant in the pathophysiology of the disorders, and drug half life. These qualities are associated to the optimum daily dosing, dose regimen and the mode of escalation of the doses of each drug, as well as to its side-effect profile. These issues will be discussed for antipsychotics and antidepressants, in a practical manner, together with general issues in pharmacotherapy related to polypharmacy and combinations with other drug classes, whenever this is appropriate.

Author information

Correspondence to Dimitrios Dikaios.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Dikaios, D. Therapeutic considerations in the treatment of major psychiatric disorders. Ann Gen Psychiatry 7, S58 (2008) doi:10.1186/1744-859X-7-S1-S58

Download citation

Keywords

  • Public Health
  • Schizophrenia
  • Psychiatric Disorder
  • Pharmacological Treatment
  • Dose Regimen